It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...

This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japan’s Pharmaceuticals and Medical Devices ...